Home » Health » Health Information » Human Health » Life Sciences » Medical Daily » Medicine » Natural Health News » Science and Health » Science and Research » NIH “Very Concerned” About AstraZeneca Trial NIH “Very Concerned” About AstraZeneca Trial September 18, 2020 Medical Daily Off Health, Health Information, Human Health, Life Sciences, Medical Daily, Medicine, Natural Health News, Science and Health, Science and Research US concerned about AstraZeneca’s COVID-19 phase 3 trial after one volunteer became ill. Read Original Article: NIH “Very Concerned” About AstraZeneca Trial » Share...FacebookPinterestTwitterLinkedinRedditTumblr Previous: Covid-19: Point of care test reports 94% sensitivity and 100% specificity compared with laboratory test Next: Medical Cannabis Can Change Lives, Thanks to New Guidelines About The Author Medical Daily